Cubist Systematic Strategies’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.1M | Sell |
|
|||||
|
2025
Q1 | $4.4M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $10.2M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.06M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.04M | Sell |
|
|||||
|
2023
Q2 | $7.49M | Sell |
|
|||||
|
2023
Q1 | $9.34M | Buy |
|
|||||
|
2022
Q4 | $10.4M | Sell |
|
|||||
|
2022
Q3 | $10.1M | Buy |
|
|||||
|
2022
Q2 | $796K | Sell |
|
|||||
|
2022
Q1 | $2.92M | Buy |
|
|||||
|
2021
Q4 | $609K | Sell |
|
|||||
|
2021
Q3 | $3.56M | Sell |
|
|||||
|
2021
Q2 | $17.4M | Buy |
|
|||||
|
2021
Q1 | $3.93M | Sell |
|
|||||
|
2020
Q4 | $10.1M | Buy |
|
|||||
|
2020
Q3 | $2.79M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $483K | Sell |
|
|||||
|
2019
Q4 | $852K | Sell |
|
|||||
|
2019
Q3 | $1.6M | Buy |
|
|||||
|
2019
Q2 | $185K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $867K | Buy |
|
|||||
|
2018
Q3 | $628K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $132K | Sell |
|
|||||
|
2017
Q4 | $268K | Sell |
|
|||||
|
2017
Q3 | $495K | Buy |
|
|||||
|
2017
Q2 | $346K | Buy |
|
|||||
|
2017
Q1 | $206K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $438K | Buy |
|
|||||
|
2015
Q4 | $387K | Sell |
|
|||||
|
2015
Q3 | $1.19M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $919K | Buy |
|
|||||
|
2014
Q4 | $459K | Buy |
|